Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Revisão |
| Språk: | engelska |
| Publicerad: |
2020
|
| Länkar: | https://doi.org/10.1080/14737159.2020.1768849 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|